Acadia Pharmaceuticals

Unverified

ManufacturerSan Diego, CAFounded 1993Nasdaq: ACAD

Overview

Acadia Pharmaceuticals is a San Diego biopharmaceutical company focused on underserved neurological and rare disease communities. It has two core franchises: neurological disease, anchored by NUPLAZID for hallucinations and delusions associated with Parkinson's disease psychosis, and rare disease, anchored by DAYBUE for Rett syndrome. The 10-K reports one business segment.

Hiring snapshot

Open roles

Newest first, from Acadia Pharmaceuticals’s careers page.

See all 10 roles →

Divisions

Division information is pending company verification.Once Acadia Pharmaceuticals claims its page, you will see each division, who it calls on and how it pays.

Claim your page

More from Acadia Pharmaceuticals

These sections fill in when Acadia Pharmaceuticals claims and verifies its page.

Life at Acadia PharmaceuticalsPhotos, stories and culture. Not added yet.
BenefitsNot added yet.
Is this your company? Claim your page →